Research Tools & Consumables Stocks Q1 Results: Benchmarking Danaher (NYSE:DHR)
The article reviews the Q1 earnings of research tools & consumables stocks, highlighting mixed results across the sector. Danaher (NYSE:DHR) reported ...
DHR
--
--
--
--
Price Chart (30 Days)
Ad Space
Analyst Sentiment
Bullish (2)
Neutral (13)
Bearish (0)
Latest DHR News
Neutral
Danaher Corp. stock (US2358511028): earnings beat keeps focus on life sciences recovery
Danaher Corp. reported a first-quarter 2026 earnings beat, exceeding Wall Street expectations, though revenue growth remained modest. The company's pe...
Neutral
Danaher Stock Forecast 2026: The Bioprocessing Equipment Cycle Has Started and Few Are Watching
Danaher (DHR) delivered a strong Q1 2026 earnings beat, with bioprocessing equipment orders growing over 30% year-over-year, signaling the start of a ...
Neutral
Danaher stock (US2358511028): spin-offs reshape the medtech group after latest quarterly numbers
Danaher is undergoing a strategic transformation through spin-offs, adapting to a softer demand environment in its core businesses. The company's firs...
Neutral
The Escalator: Rx&O, Danaher, Ruder Finn and more
This article provides an "Escalator" update on recent leadership changes and significant news across the pharma, biotech, and medical marketing indust...
Bullish
Cepheid Receives CE Marking Under IVDR for Xpert® GI Panel
Cepheid, a Danaher company, has received CE marking under the IVDR for its Xpert GI Panel. This multiplex PCR test quickly and accurately detects 11 c...
Neutral
How Danaher’s New Euro Debt, Dividend and Conferences At Danaher (DHR) Has Changed Its Investment Story
Danaher Corporation recently issued €3.00 billion in senior notes, affirmed its quarterly dividend, and participated in industry conferences, indicati...
Neutral
Is Danaher (DHR) Pricing Look Interesting After Recent Life Sciences Portfolio Focus News
This article analyzes Danaher (DHR)'s stock valuation after recent news focusing on its life sciences portfolio. Using a Discounted Cash Flow (DCF) an...
Neutral
Danaher Corp. Stock (US2358511028): Analyst Downgrades and 52-Week Low Test
Danaher Corp. (NYSE: DHR) shares have fallen to a new 52-week low of $172, driven by recent analyst downgrades and mixed Q1 2026 results that beat EPS...
Neutral
Danaher Uses Euro Debt For Masimo Deal As Valuation Gap Widens
Danaher (NYSE:DHR) has initiated a multi-billion euro debt offering to primarily fund its acquisition of Masimo Corporation. This strategic move aims ...
Bullish
Danaher Corporation (DHR) Announces Issuance of €3 Billion in Senior Notes
Danaher Corporation (DHR) has announced the issuance of €3 billion in senior notes across various maturities, including floating and fixed-rate notes....
Neutral
Advisors Capital Management LLC Has $12.56 Million Stock Position in Danaher Corporation $DHR
Advisors Capital Management LLC significantly increased its stake in Danaher Corporation during Q4, now holding 54,845 shares valued at $12.56 million...
Neutral
Danaher prices €3 billion senior notes offering
Danaher Corporation has priced an offering of €3 billion in euro-denominated senior notes across four tranches, with proceeds intended to fund the acq...
Neutral
Danaher Corp Estimates Net Proceeds From Senior Notes Sale At 2.98 Billion Euros
Danaher Corp has announced its estimate for net proceeds from a senior notes sale, totaling 2.98 billion Euros. This information was reported by Reute...
Neutral
To help fund its Masimo acquisition, Danaher prices €3B debt
Danaher Corporation has priced a €3.0 billion senior notes offering across four tranches due 2028, 2030, 2034, and 2038 to primarily fund its acquisit...
Research DHR on:
Ad Space